First our observation that MGMT promoter hypermethylation is associated with enhanced plasticity or permissivity towards adaptive resistance appears counterintuitive since hypermethylation is routinely clinically viewed as a favorable biomarker in GBM. The gene discussed is MGMT; the disease is glioblastoma.